Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000137 |
| _version_ | 1797282215279722496 |
|---|---|
| author | Simon Hallam |
| author_facet | Simon Hallam |
| author_sort | Simon Hallam |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:09:45Z |
| format | Article |
| id | doaj.art-5cf183012dd247e191af73eb61da5e29 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:09:45Z |
| publishDate | 2018-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-5cf183012dd247e191af73eb61da5e292024-03-03T01:24:35ZengWileyHemaSphere2572-92412018-08-012410.1097/HS9.0000000000000137201808000-00002Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin LymphomaSimon Hallam0St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdomhttp://journals.lww.com/10.1097/HS9.0000000000000137 |
| spellingShingle | Simon Hallam Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma HemaSphere |
| title | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_full | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_fullStr | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_full_unstemmed | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_short | Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma |
| title_sort | dual immunotherapy adds value in relapsed refractory hodgkin lymphoma |
| url | http://journals.lww.com/10.1097/HS9.0000000000000137 |
| work_keys_str_mv | AT simonhallam dualimmunotherapyaddsvalueinrelapsedrefractoryhodgkinlymphoma |